Deutsche Bank’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.9M | Sell |
1,496,296
-280,280
| -16% | -$4.85M | 0.01% | 763 |
|
|
2025
Q1 | $38.9M | Sell |
1,776,576
-1,801
| -0.1% | -$39.4K | 0.02% | 675 |
|
|
2024
Q4 | $56.7M | Buy |
1,778,377
+30,867
| +2% | +$985K | 0.02% | 610 |
|
|
2024
Q3 | $50.4M | Sell |
1,747,510
-94,532
| -5% | -$2.73M | 0.02% | 598 |
|
|
2024
Q2 | $70.7M | Buy |
1,842,042
+230,269
| +14% | +$8.83M | 0.03% | 459 |
|
|
2024
Q1 | $94.7M | Buy |
1,611,773
+754,774
| +88% | +$44.4M | 0.04% | 368 |
|
|
2023
Q4 | $51.3M | Buy |
856,999
+532,705
| +164% | +$31.9M | 0.03% | 527 |
|
|
2023
Q3 | $12.3M | Sell |
324,294
-154,072
| -32% | -$5.86M | 0.01% | 817 |
|
|
2023
Q2 | $43.6M | Sell |
478,366
-121,062
| -20% | -$11M | 0.02% | 547 |
|
|
2023
Q1 | $39.5M | Buy |
599,428
+336,251
| +128% | +$22.2M | 0.02% | 572 |
|
|
2022
Q4 | $13.6M | Sell |
263,177
-304,568
| -54% | -$15.7M | 0.01% | 864 |
|
|
2022
Q3 | $38.8M | Sell |
567,745
-126,862
| -18% | -$8.66M | 0.02% | 570 |
|
|
2022
Q2 | $31.4M | Buy |
694,607
+150,296
| +28% | +$6.8M | 0.02% | 660 |
|
|
2022
Q1 | $27.7M | Buy |
544,311
+205,558
| +61% | +$10.4M | 0.01% | 752 |
|
|
2021
Q4 | $16M | Buy |
338,753
+47,744
| +16% | +$2.26M | 0.01% | 926 |
|
|
2021
Q3 | $9.59M | Sell |
291,009
-28,952
| -9% | -$954K | ﹤0.01% | 1178 |
|
|
2021
Q2 | $20.2M | Sell |
319,961
-99,699
| -24% | -$6.3M | 0.01% | 896 |
|
|
2021
Q1 | $18M | Sell |
419,660
-214,077
| -34% | -$9.19M | 0.01% | 935 |
|
|
2020
Q4 | $36.3M | Buy |
633,737
+76,506
| +14% | +$4.38M | 0.02% | 609 |
|
|
2020
Q3 | $16.8M | Buy |
557,231
+12,144
| +2% | +$366K | 0.01% | 763 |
|
|
2020
Q2 | $17.8M | Buy |
545,087
+359,645
| +194% | +$11.7M | 0.01% | 731 |
|
|
2020
Q1 | $4.97M | Buy |
185,442
+20,432
| +12% | +$547K | ﹤0.01% | 1243 |
|
|
2019
Q4 | $5.05M | Buy |
165,010
+34,247
| +26% | +$1.05M | ﹤0.01% | 1441 |
|
|
2019
Q3 | $3.15M | Buy |
130,763
+16,399
| +14% | +$395K | ﹤0.01% | 1649 |
|
|
2019
Q2 | $2.9M | Sell |
114,364
-13,152
| -10% | -$333K | ﹤0.01% | 2142 |
|
|
2019
Q1 | $2.49M | Buy |
127,516
+101,431
| +389% | +$1.98M | ﹤0.01% | 2320 |
|
|
2018
Q4 | $343K | Sell |
26,085
-98,833
| -79% | -$1.3M | ﹤0.01% | 3505 |
|
|
2018
Q3 | $2.22M | Buy |
124,918
+54,996
| +79% | +$977K | ﹤0.01% | 2774 |
|
|
2018
Q2 | $1.54M | Buy |
69,922
+55,538
| +386% | +$1.22M | ﹤0.01% | 3111 |
|
|
2018
Q1 | $317K | Sell |
14,384
-9,424
| -40% | -$208K | ﹤0.01% | 3867 |
|
|
2017
Q4 | $516K | Buy |
+23,808
| New | +$516K | ﹤0.01% | 3495 |
|